LogoLogoMSF Science Portal
  • My saved items
logo

© Médecins Sans Frontières

MSF Science Portal
About MSF Science Portal
About MSF
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use

v2.1.4829.produseast1

Journal Article > Research

A cluster randomized non-inferiority field trial on the immunogenicity and safety of tetanus toxoid vaccine kept in controlled temperature chain compared to cold chain

Juan-Giner A, Domicent C, Langendorf C, Roper M, Baoundoh P, Fermon F, Gakima P, Zipursky S, Tamadji M, Grais RF
Download
Download
Abstract
In resource-poor settings, cold chain requirements present barriers for vaccine delivery. We evaluated the immunogenicity and safety of tetanus toxoid (TT) vaccine in "Controlled Temperature Chain" (CTC; up to 40°C for <30 days before administration), compared to standard cold chain (SCC; 2-8°C). Prior to the study, stability parameters of TT-CTC were shown to meet international requirements.
Countries
Chad
Subject Area
vaccination
DOI
10.1016/j.vaccine.2014.09.027
Published Date
23-Sep-2014
PubMed ID
25261378
Languages
English
Journal
Vaccine
Volume / Issue / Pages
Volume 32, Issue 47
Issue Date
01-Oct-2014
Dimensions Badge